About the Company
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $HRTX News
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call March 12, 2024 Heron Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at ...
Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in acute and oncology care franchises.
Heron Therapeutics, Inc.: Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
ZYNRELEF® achieved quarterly record of $5.6 million in Q4 Net Product Sales Ended 2023 with cash and cash equivalents ...
Heron Therapeutics: Q4 Earnings Snapshot
SAN DIEGO — SAN DIEGO — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $10.7 million in its fourth quarter. The San Diego-based company said it had a loss of 7 cents per share. The ...
Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Heron Therapeutics (HRTX – Research Report), ...
Biotech Stock News Bite - Heron Therapeutics, Inc. (Nasdaq: HRTX) Higher On Fourth Quarter And Full-Year 2023 Financial Results
Biotech Stock News Bites - Heron Therapeutics, Inc. (Nasdaq: HRTX ), a commercial-stage biotechnology company, is on the NASDAQ to ...
Heron Therapeutics: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $10.7 million in its fourth quarter. The San Diego-based company said it had a loss of 7 cents ...
Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript
Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call. I would now like to welcome Melissa Durel [ph], Executive Director, Legal to begin the call.
Q4 2023 Heron Therapeutics Inc Earnings Call
Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 conference call. I would now like to welcome Melissa Duran, Executive Director, legal to begin the call. Melissa, ...
Loading the latest forecasts...